# Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

> **NCT03122483** · — · COMPLETED · sponsor: **Beckman Coulter, Inc.** · enrollment: 250 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DIAGNOSTIC_TEST:** blood biomarker

## Key facts

- **NCT ID:** NCT03122483
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-07-14
- **Final completion:** 2017-07-14
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2017-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122483, "Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03122483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*